Plain-English translation of NCT05794035 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying radiation therapy for older patients (age 70+) who have had surgery for non-melanoma skin cancer with features that increase the risk of the cancer coming back. Researchers want to compare three approaches: surgery alone, surgery followed by a moderate-length radiation course (3 weeks), or surgery followed by a very short radiation course (5 weeks with one treatment per week). The goal is to find out which approach works best while keeping older patients' quality of life in mind.
About 5–10% of non-melanoma skin cancers have features that make them more likely to return after surgery. While radiation therapy after surgery might help prevent recurrence, doctors aren't sure if it's worth the burden on older patients or which radiation schedule works best. This trial aims to answer those questions specifically for older adults, since most research hasn't focused on their needs.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to one of three groups: surgery only, surgery plus moderate-dose radiation (15 treatments over 5 weeks, 3 days per week), or surgery plus very short-course radiation (5 treatments over 5 weeks, 1 day per week). You will have follow-up appointments to monitor how well the treatment worked, any side effects, how your skin heals, and your overall quality of life. The study involves about 303 patients across multiple centers and will follow you for some time after treatment to track your recovery and cancer recurrence rates.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France